Why Sarepta? Why Now?
The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development in gene therapy, RNA and gene editing. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne.
We’re looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients.
What Sarepta Offers
At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas:
Physical and Emotional Wellness
Financial Wellness
Support for Caregivers
For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us
The Importance of the Role
We are seeking a Senior Manager who will be responsible for the project management of advisory board meetings to support the execution of Sarepta’s Advisory Board Plan, as well as other opinion leader engagements. This individual will be key in collaborating with cross functional partners (Medical Affairs, Clinical Development, etc.) to determine and develop the scientific content that will be shared at advisory boards to ensure robust feedback on Sarepta’s objectives. This individual should have a strong understanding of the biotech environment for rare diseases and deep therapeutic knowledge of the mechanism of action of the different precision genetic medicines offered by Sarepta commercially and in clinical development.The Opportunity to Make a Difference
Project management of advisory board meetings to support execution of strategic plan
Development of project timelines and management of workstreams to support timely execution
Liaising with cross-functional stakeholders to support content development and related workstreams according to timelines
Oversight of vendors to support advisory board activities
Management of documentation related to HCP engagements and advisory board meetings
Ensuring adherence to Compliance requirements for HCP engagements
Have an in-depth understanding of RNA therapeutics, gene therapy, and siRNA-based treatments
Serve as a product expert and share KOL insights as a member of GBTs & GPTs
Lead the creation and review of high-quality scientific content for advisory board materials
Identify opportunities for program enhancement and provide strategic input to cross-functional teams.
More about You
- PharmD, PhD, or advanced science degree REQUIRED
- 5+ years of experience in rare disease biotech
- Proven track-record of project management skills
- Excellent written and verbal communication skills, with a sharp eye for scientific detail and narrative flow
- Ability to manage multiple projects and priorities in a fast-paced environment
- Highly proficient in Microsoft Office suite (Outlook, Excel, Word, PowerPoint, Visio)
What Now?
We’re always looking for solution-oriented, critical thinkers.
So, if you’re comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply.
Top Skills
Sarepta Therapeutics Cambridge, Massachusetts, USA Office
215 First Street, Cambridge, MA, United States, 02142
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories